Julia Raitanen

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Quality Control

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Raitanen, Bernadette Barta, Marcus Hacker, Dietmar Georg, Theresa Balber, Markus Mitterhauser
Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines. Cells 12 (3) (2023)
Julia Raitanen, Bernadette Barta, Marcus Hacker, Dietmar Georg, Theresa Balber, Markus Mitterhauser
Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines. Cells 12 (3) (2023)
Julia Raitanen, Bernadette Barta, Hermann Fuchs, Marcus Hacker, Theresa Balber, Dietmar Georg, Markus Mitterhauser
Radiobiological Assessment of Targeted Radionuclide Therapy with [ 177 Lu]Lu-PSMA-I&T in 2D vs. 3D Cell Culture Models. International journal of molecular sciences 24 (23) (2023)
Julia Raitanen, Bernadette Barta, Marcus Hacker, Dietmar Georg, Theresa Balber, Markus Mitterhauser
Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines. Cells 12 (3) (2023)
Stefan Schmitl, Julia Raitanen, Stephan Witoszynskyj, Eva-Maria Patronas, Lukas Nics, Marius Ozenil, Victoria Weissenböck, Thomas L Mindt, Marcus Hacker, Wolfgang Wadsak, Marie R Brandt, Markus Mitterhauser
Quality Assurance Investigations and Impurity Characterization during Upscaling of [ 177 Lu]Lu-PSMA I&T . Molecules (Basel, Switzerland) 28 (23) (2023)
Julia Raitanen, Bernadette Barta, Marcus Hacker, Dietmar Georg, Theresa Balber, Markus Mitterhauser
Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines. Cells 12 (3) (2023)
Theresa Balber, Loan Tran, Katarína Benčurová, Julia Raitanen, Gerda Egger, Markus Mitterhauser
Experimental Nuclear Medicine Meets Tumor Biology. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)